Diltiazem
(HDRXZJPWHTXQRI-BHDTVMLSSA-N)
Structure
- SMILES
- COc1ccc(cc1)[C@@H]1Sc2ccccc2N(C(=O)[C@@H]1OC(=O)C)CCN(C)C.Cl
- Molecular Formula:
- C22H27ClN2O4S
- Molecular Weight:
- 450.979
- Log P:
- 4.2355
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 1
- TPSA:
- 84.38
- CAS Number(s):
- 33286-22-5; 38411-61-9; 103532-26-9
Synonym(s)
1.
Diltiazem
2.
Aldizem
3.
CRD-401
4.
Cardil
5.
Cardizem
6.
Dilacor
7.
Dilacor XR
8.
Dilren
9.
Diltiazem Hydrochloride
10.
Diltiazem Malate
11.
Dilzem
12.
Tiazac
13.
CRD 401
14.
CRD401
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Completed Suicide | FAERS: 117 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Drug ineffective | FAERS: 60 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 3 | Hypotension | FAERS: 58 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 4 | Bradycardia | FAERS: 55 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 5 | Dizziness | FAERS: 51 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 6 | Headache | FAERS: 45 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 7 | Overdose | FAERS: 45 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Nausea | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Toxicity to various agents | FAERS: 37 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 10 | Vomiting | FAERS: 36 | US FAERS | |
| 11 | Product substitution issue | FAERS: 34 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Cardiac Arrest | FAERS: 29 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Fatigue | FAERS: 29 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 14 | Asthenia | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Medication Error | FAERS: 26 | US FAERS | |
| 16 | Shock | FAERS: 25 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 17 | Suicide attempt | FAERS: 24 | US FAERS | |
| 18 | Metabolic acidosis | FAERS: 23 | US FAERS | |
| 19 | Pharmaceutical product complaint | FAERS: 23 | US FAERS | |
| 20 | Medication residue present | FAERS: 22 | US FAERS | |
| 21 | Poisoning | FAERS: 21 | US FAERS | |
| 22 | Malaise | FAERS: 20 | US FAERS | |
| 23 | Pruritus | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 24 | Atrial Fibrillation | FAERS: 18 | US FAERS | |
| 25 | Chest Pain | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 26 | Joint swelling | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Product quality issue | FAERS: 17 | US FAERS | |
| 28 | Palpitations | FAERS: 16 | US FAERS | |
| 29 | Tachycardia | FAERS: 16 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 30 | Urticaria | FAERS: 16 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 31 | Wrong technique in product usage process | FAERS: 13 | US FAERS | |
| 32 | Abdominal discomfort | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 33 | Atrioventricular Block | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 34 | Chest discomfort | FAERS: 12 | US FAERS | |
| 35 | Peripheral swelling | FAERS: 12 | US FAERS | |
| 36 | Aspartate Aminotransferase Increased | FAERS: 11 | US FAERS | |
| 37 | Erythema | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 38 | Hypersensitivity | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 39 | Tremor | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Alanine Aminotransferase Increased | FAERS: 10 | US FAERS | |
| 41 | Alopecia | FAERS: 10 | US FAERS | |
| 42 | Anuria | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 43 | Flushing | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Hypoxia | FAERS: 10 | US FAERS | |
| 45 | Swelling | FAERS: 10 | US FAERS | |
| 46 | Blood glucose increased | FAERS: 9 | US FAERS | |
| 47 | Therapeutic response unexpected with drug substitution | FAERS: 9 | US FAERS | |
| 48 | Acute kidney injury | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Drug dispensing error | FAERS: 8 | US FAERS | |
| 50 | Feeling abnormal | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 51 | Hepatotoxicity | FAERS: 8 | US FAERS | |
| 52 | Incorrect dose administered | FAERS: 8 | US FAERS | |
| 53 | Product use in unapproved indication | FAERS: 8 | US FAERS | |
| 54 | Respiratory arrest | FAERS: 8 | US FAERS | |
| 55 | Somnolence | FAERS: 8 | US FAERS | |
| 56 | Abdominal Pain | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 57 | Constipation | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 58 | Respiratory Failure | FAERS: 7 | US FAERS | |
| 59 | Sinus bradycardia | FAERS: 7 | US FAERS | |
| 60 | Ventricular Fibrillation | FAERS: 7 | US FAERS | |
| 61 | Accidental drug intake by child | FAERS: 6 | US FAERS | |
| 62 | Accidental overdose | FAERS: 6 | US FAERS | |
| 63 | Acidosis | FAERS: 6 | US FAERS | |
| 64 | Blood pressure inadequately controlled | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 65 | Dyspepsia | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 66 | Erythema Multiforme | FAERS: 6 | US FAERS | |
| 67 | Exposure via ingestion | FAERS: 6 | US FAERS | |
| 68 | Multi-organ disorder | FAERS: 6 | US FAERS | |
| 69 | Oliguria | FAERS: 6 | US FAERS | |
| 70 | Stevens-Johnson Syndrome | FAERS: 6 | US FAERS | |
| 71 | Tinnitus | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 72 | Anxiety | FAERS: 5 | US FAERS | |
| 73 | Back Pain | FAERS: 5 | US FAERS | |
| 74 | Blood lactate dehydrogenase increased | FAERS: 5 | US FAERS | |
| 75 | Cerebrovascular accident | FAERS: 5 | US FAERS | |
| 76 | Dermatitis | FAERS: 5 | US FAERS | |
| 77 | Intentional product misuse | FAERS: 5 | US FAERS | |
| 78 | Medication residue | FAERS: 5 | US FAERS | |
| 79 | Mucosal erosion | FAERS: 5 | US FAERS | |
| 80 | Product taste abnormal | FAERS: 5 | US FAERS | |
| 81 | Product use complaint | FAERS: 5 | US FAERS | |
| 82 | Product use issue | FAERS: 5 | US FAERS | |
| 83 | Syncope | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Adverse event | FAERS: 4 | US FAERS | |
| 85 | Anaphylactic shock | FAERS: 4 | US FAERS | |
| 86 | Angioedema | FAERS: 4 | US FAERS | |
| 87 | Blood alkaline phosphatase increased | FAERS: 4 | US FAERS | |
| 88 | Blood creatinine increased | FAERS: 4 | US FAERS | |
| 89 | Burning sensation | FAERS: 4 | US FAERS | |
| 90 | Cyanosis | FAERS: 4 | US FAERS | |
| 91 | Drug dose omission | FAERS: 4 | US FAERS | |
| 92 | Eye irritation | FAERS: 4 | US FAERS | |
| 93 | General physical health deterioration | FAERS: 4 | US FAERS | |
| 94 | Hypoperfusion | FAERS: 4 | US FAERS | |
| 95 | Mental status changes | FAERS: 4 | US FAERS | |
| 96 | No adverse event | FAERS: 4 | US FAERS | |
| 97 | Pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 98 | Presyncope | FAERS: 4 | US FAERS | |
| 99 | Product size issue | FAERS: 4 | US FAERS | |
| 100 | Skin test positive | FAERS: 4 | US FAERS | |
| 101 | Vasoplegia syndrome | FAERS: 4 | US FAERS | |
| 102 | Vertigo | FAERS: 4 | US FAERS | |
| 103 | Accidental exposure | FAERS: 3 | US FAERS | |
| 104 | Conjunctivitis | FAERS: 3 | US FAERS | |
| 105 | Crying | FAERS: 3 | US FAERS | |
| 106 | Drug exposure during pregnancy | FAERS: 3 | US FAERS | |
| 107 | Dysarthria | FAERS: 3 | US FAERS | |
| 108 | Dysphonia | FAERS: 3 | US FAERS | |
| 109 | Epistaxis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 110 | Eye pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 111 | Foreign body trauma | FAERS: 3 | US FAERS | |
| 112 | Intentional misuse | FAERS: 3 | US FAERS | |
| 113 | Leukocytosis | FAERS: 3 | US FAERS | |
| 114 | Lip swelling | FAERS: 3 | US FAERS | |
| 115 | Pancytopenia | FAERS: 3 | US FAERS | |
| 116 | Rash erythematous | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 117 | Sluggishness | FAERS: 3 | US FAERS | |
| 118 | Supraventricular tachycardia | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 119 | Unevaluable event | FAERS: 3 | US FAERS | |
| 120 | Visual Impairment | FAERS: 3 | US FAERS | |
| 121 | Abdominal Compartment Syndrome | FAERS: 2 | US FAERS | |
| 122 | Acute Lung Injury | FAERS: 2 | US FAERS | |
| 123 | Agranulocytosis | FAERS: 2 | US FAERS | |
| 124 | Amnesia | FAERS: 2 | US FAERS | |
| 125 | Anorexia | FAERS: 2 | US FAERS | |
| 126 | Aortic Aneurysm | FAERS: 2 | US FAERS | |
| 127 | Arthralgia | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 128 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 129 | Blood creatine increased | FAERS: 2 | US FAERS | |
| 130 | Cataract | FAERS: 2 | US FAERS | |
| 131 | Caustic injury | FAERS: 2 | US FAERS | |
| 132 | Choking | FAERS: 2 | US FAERS | |
| 133 | Cholestasis | FAERS: 2 | US FAERS | |
| 134 | Cytolytic hepatitis | FAERS: 2 | US FAERS | |
| 135 | Deafness | FAERS: 2 | US FAERS | |
| 136 | Dehydration | FAERS: 2 | US FAERS | |
| 137 | Demyelination | FAERS: 2 | US FAERS | |
| 138 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 139 | Device capturing issue | FAERS: 2 | US FAERS | |
| 140 | Diabetic Ketoacidosis | FAERS: 2 | US FAERS | |
| 141 | Diverticulum | FAERS: 2 | US FAERS | |
| 142 | Drug abuse | FAERS: 2 | US FAERS | |
| 143 | Drug administration error | FAERS: 2 | US FAERS | |
| 144 | Electrolyte imbalance | FAERS: 2 | US FAERS | |
| 145 | Epigastric discomfort | FAERS: 2 | US FAERS | |
| 146 | Extravasation | FAERS: 2 | US FAERS | |
| 147 | Flatulence | FAERS: 2 | US FAERS | |
| 148 | Gastritis | FAERS: 2 | US FAERS | |
| 149 | Hepatitis | FAERS: 2 | US FAERS | |
| 150 | Hypothyroidism | FAERS: 2 | US FAERS | |
| 151 | Iatrogenic injury | FAERS: 2 | US FAERS | |
| 152 | Idiosyncratic drug reaction | FAERS: 2 | US FAERS | |
| 153 | Intentional drug misuse | FAERS: 2 | US FAERS | |
| 154 | Intentional self-injury | FAERS: 2 | US FAERS | |
| 155 | Lethargy | FAERS: 2 | US FAERS | |
| 156 | Mood swings | FAERS: 2 | US FAERS | |
| 157 | Musculoskeletal Pain | FAERS: 2 | US FAERS | |
| 158 | Musculoskeletal stiffness | FAERS: 2 | US FAERS | |
| 159 | Oropharyngeal pain | FAERS: 2 | US FAERS | |
| 160 | Pharmaceutical product counterfeit | FAERS: 2 | US FAERS | |
| 161 | Pneumonia | FAERS: 2 | US FAERS | |
| 162 | Poor quality drug administered | FAERS: 2 | US FAERS | |
| 163 | Prescribed overdose | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 164 | Product preparation error | FAERS: 2 | US FAERS | |
| 165 | Product residue present | FAERS: 2 | US FAERS | |
| 166 | Reaction to excipient | FAERS: 2 | US FAERS | |
| 167 | Sinoatrial Block | FAERS: 2 | US FAERS | |
| 168 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 169 | Skin lesion | FAERS: 2 | US FAERS | |
| 170 | Sneezing | FAERS: 2 | US FAERS | |
| 171 | Therapeutic response unexpected | FAERS: 2 | US FAERS | |
| 172 | Therapy cessation | FAERS: 2 | US FAERS | |
| 173 | Therapy non-responder | FAERS: 2 | US FAERS | |
| 174 | Throat irritation | FAERS: 2 | US FAERS | |
| 175 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 176 | Weight decreased | FAERS: 2 | US FAERS | |
| 177 | Wheezing | FAERS: 2 | US FAERS | |
| 178 | White blood cell count decreased | FAERS: 2 | US FAERS | |
| 179 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 180 | nervous system disorder | FAERS: 2 | US FAERS | |
| 181 | treatment failure | FAERS: 2 | US FAERS | |
| 182 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 183 | Acne | FAERS: 1 | US FAERS | |
| 184 | Acute prerenal failure | FAERS: 1 | US FAERS | |
| 185 | Adactyly | FAERS: 1 | US FAERS | |
| 186 | Adams-Stokes Syndrome | FAERS: 1 | US FAERS | |
| 187 | Ageusia | FAERS: 1 | US FAERS | |
| 188 | Agitation | FAERS: 1 | US FAERS | |
| 189 | Allergy to arthropod sting | FAERS: 1 | US FAERS | |
| 190 | Amylase increased | FAERS: 1 | US FAERS | |
| 191 | Anal Fissure | FAERS: 1 | US FAERS | |
| 192 | Anal spasm | FAERS: 1 | US FAERS | |
| 193 | Aneurysm | FAERS: 1 | US FAERS | |
| 194 | Anger | FAERS: 1 | US FAERS | |
| 195 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 196 | Anhidrosis | FAERS: 1 | US FAERS | |
| 197 | Apathy | FAERS: 1 | US FAERS | |
| 198 | Arthropathy | FAERS: 1 | US FAERS | |
| 199 | Arthropod sting | FAERS: 1 | US FAERS | |
| 200 | Asthma | FAERS: 1 | US FAERS | |
| 201 | Ataxia | FAERS: 1 | US FAERS | |
| 202 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 203 | Auricular swelling | FAERS: 1 | US FAERS | |
| 204 | Blister rupture | FAERS: 1 | US FAERS | |
| 205 | Blood creatine phosphokinase increased | FAERS: 1 | US FAERS | |
| 206 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 207 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 208 | Blood immunoglobulin M decreased | FAERS: 1 | US FAERS | |
| 209 | Blood potassium decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 210 | Blood potassium increased | FAERS: 1 | US FAERS | |
| 211 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 212 | Blood sodium decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 213 | Bone pain | FAERS: 1 | US FAERS | |
| 214 | Bowel movement irregularity | FAERS: 1 | US FAERS | |
| 215 | Capsule physical issue | FAERS: 1 | US FAERS | |
| 216 | Carbon Monoxide Poisoning | FAERS: 1 | US FAERS | |
| 217 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 218 | Cardiomegaly | FAERS: 1 | US FAERS | |
| 219 | Cardiotoxicity | FAERS: 1 | US FAERS | |
| 220 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 221 | Cerebral atrophy | FAERS: 1 | US FAERS | |
| 222 | Cheilitis | FAERS: 1 | US FAERS | |
| 223 | Chills | FAERS: 1 | US FAERS | |
| 224 | Cluster Headache | FAERS: 1 | US FAERS | |
| 225 | Colonic Pseudo-Obstruction | FAERS: 1 | US FAERS | |
| 226 | Coma scale abnormal | FAERS: 1 | US FAERS | |
| 227 | Crystalluria | FAERS: 1 | US FAERS | |
| 228 | Depressed mood | FAERS: 1 | US FAERS | |
| 229 | Device computer issue | FAERS: 1 | US FAERS | |
| 230 | Device malfunction | FAERS: 1 | US FAERS | |
| 231 | Device use issue | FAERS: 1 | US FAERS | |
| 232 | Diabetes Mellitus | FAERS: 1 | US FAERS | |
| 233 | Diplopia | FAERS: 1 | US FAERS | |
| 234 | Discomfort | FAERS: 1 | US FAERS | |
| 235 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 236 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 237 | Drug level increased | FAERS: 1 | US FAERS | |
| 238 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 239 | Drug toxicity | FAERS: 1 | US FAERS | |
| 240 | Dysgeusia | FAERS: 1 | US FAERS | |
| 241 | Dystonia | FAERS: 1 | US FAERS | |
| 242 | Eczema | FAERS: 1 | US FAERS | |
| 243 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 244 | Electrocardiogram ST segment abnormal | FAERS: 1 | US FAERS | |
| 245 | Emotional disorder | FAERS: 1 | US FAERS | |
| 246 | Emotional distress | FAERS: 1 | US FAERS | |
| 247 | Epidermal necrosis | FAERS: 1 | US FAERS | |
| 248 | Eructation | FAERS: 1 | US FAERS | |
| 249 | Exfoliation Syndrome | FAERS: 1 | US FAERS | |
| 250 | Exophthalmos | FAERS: 1 | US FAERS | |
| 251 | Facial Paresis | FAERS: 1 | US FAERS | |
| 252 | Food Allergy | FAERS: 1 | US FAERS | |
| 253 | Frustration tolerance decreased | FAERS: 1 | US FAERS | |
| 254 | Gait inability | FAERS: 1 | US FAERS | |
| 255 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 256 | Genital Herpes | FAERS: 1 | US FAERS | |
| 257 | Genital erosion | FAERS: 1 | US FAERS | |
| 258 | Glaucoma | FAERS: 1 | US FAERS | |
| 259 | HELLP Syndrome | FAERS: 1 | US FAERS | |
| 260 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 261 | Hepatitis C | FAERS: 1 | US FAERS | |
| 262 | Hordeolum | FAERS: 1 | US FAERS | |
| 263 | Human herpes virus 6 serology positive | FAERS: 1 | US FAERS | |
| 264 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 265 | Hypokinesia | FAERS: 1 | US FAERS | |
| 266 | Idiopathic Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 267 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 268 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 269 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 270 | Increased tendency to bruise | FAERS: 1 | US FAERS | |
| 271 | Inflammation | FAERS: 1 | US FAERS | |
| 272 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 273 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 274 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 275 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 276 | Lupus-like syndrome | FAERS: 1 | US FAERS | |
| 277 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 278 | Macular degeneration | FAERS: 1 | US FAERS | |
| 279 | Macule | FAERS: 1 | US FAERS | |
| 280 | Mechanical ventilation | FAERS: 1 | US FAERS | |
| 281 | Medication tampering | FAERS: 1 | US FAERS | |
| 282 | Memory impairment | FAERS: 1 | US FAERS | |
| 283 | Mental impairment | FAERS: 1 | US FAERS | |
| 284 | Middle insomnia | FAERS: 1 | US FAERS | |
| 285 | Migraine with Aura | FAERS: 1 | US FAERS | |
| 286 | Multiple drug overdose | FAERS: 1 | US FAERS | |
| 287 | Muscle Rigidity | FAERS: 1 | US FAERS | |
| 288 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 289 | Myalgia | FAERS: 1 | US FAERS | |
| 290 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 291 | Nephrolithiasis | FAERS: 1 | US FAERS | |
| 292 | Nervousness | FAERS: 1 | US FAERS | |
| 293 | Nocturia | FAERS: 1 | US FAERS | |
| 294 | Osteopenia | FAERS: 1 | US FAERS | |
| 295 | Pain of skin | FAERS: 1 | US FAERS | |
| 296 | Pallor | FAERS: 1 | US FAERS | |
| 297 | Petechiae | FAERS: 1 | US FAERS | |
| 298 | Photophobia | FAERS: 1 | US FAERS | |
| 299 | Pneumothorax | FAERS: 1 | US FAERS | |
| 300 | Postoperative infection | FAERS: 1 | US FAERS | |
| 301 | Product availability issue | FAERS: 1 | US FAERS | |
| 302 | Product commingling | FAERS: 1 | US FAERS | |
| 303 | Product compounding quality issue | FAERS: 1 | US FAERS | |
| 304 | Product container issue | FAERS: 1 | US FAERS | |
| 305 | Product dispensing error | FAERS: 1 | US FAERS | |
| 306 | Product dose omission | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 307 | Product formulation issue | FAERS: 1 | US FAERS | |
| 308 | Product label issue | FAERS: 1 | US FAERS | |
| 309 | Product physical consistency issue | FAERS: 1 | US FAERS | |
| 310 | Product physical issue | FAERS: 1 | US FAERS | |
| 311 | Product prescribing error | FAERS: 1 | US FAERS | |
| 312 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 313 | Product supply issue | FAERS: 1 | US FAERS | |
| 314 | Productive Cough | FAERS: 1 | US FAERS | |
| 315 | Proteinuria | FAERS: 1 | US FAERS | |
| 316 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 317 | Reaction to drug excipients | FAERS: 1 | US FAERS | |
| 318 | Renal Artery Stenosis | FAERS: 1 | US FAERS | |
| 319 | Residual urine | FAERS: 1 | US FAERS | |
| 320 | Respiratory distress | FAERS: 1 | US FAERS | |
| 321 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 322 | Retching | FAERS: 1 | US FAERS | |
| 323 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 324 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 325 | Sick Sinus Syndrome | FAERS: 1 | US FAERS | |
| 326 | Sinus Arrhythmia | FAERS: 1 | US FAERS | |
| 327 | Sinusitis | FAERS: 1 | US FAERS | |
| 328 | Skin Erosion | FAERS: 1 | US FAERS | |
| 329 | Skin necrosis | FAERS: 1 | US FAERS | |
| 330 | Skin tightness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 331 | Soft tissue necrosis | FAERS: 1 | US FAERS | |
| 332 | Stoma site irritation | FAERS: 1 | US FAERS | |
| 333 | Stomatitis | FAERS: 1 | US FAERS | |
| 334 | Stress | FAERS: 1 | US FAERS | |
| 335 | Sudden death | FAERS: 1 | US FAERS | |
| 336 | Swelling of eyelid | FAERS: 1 | US FAERS | |
| 337 | Tetany | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 338 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 339 | Throat cancer | FAERS: 1 | US FAERS | |
| 340 | Thrombosis | FAERS: 1 | US FAERS | |
| 341 | Toxic Epidermal Necrolysis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 342 | Tracheal pain | FAERS: 1 | US FAERS | |
| 343 | Transcription medication error | FAERS: 1 | US FAERS | |
| 344 | Traumatic fracture | FAERS: 1 | US FAERS | |
| 345 | Trichorrhexis | FAERS: 1 | US FAERS | |
| 346 | Troponin increased | FAERS: 1 | US FAERS | |
| 347 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 348 | Vascular purpura | FAERS: 1 | US FAERS | |
| 349 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 350 | Ventricular arrhythmia | FAERS: 1 | US FAERS | |
| 351 | Ventricular hypertrophy | FAERS: 1 | US FAERS | |
| 352 | Wrong dose | FAERS: 1 | US FAERS | |
| 353 | Wrong product administered | FAERS: 1 | US FAERS | |
| 354 | jaundice | FAERS: 1 | US FAERS | |
| 355 | Blindness | Canada Vigilance: 1 | Canada Vigilance | |
| 356 | Eyelid pain | Canada Vigilance: 1 | Canada Vigilance | |
| 357 | Joint stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 358 | Osteoporosis | Canada Vigilance: 1 | Canada Vigilance | |
| 359 | Pancreatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 360 | Pathological fracture | Canada Vigilance: 1 | Canada Vigilance | |
| 361 | Retinal Detachment | Canada Vigilance: 1 | Canada Vigilance | |
| 362 | Urinary Retention | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.